Related Experiment Video
Updated: Jun 17, 2026

07:44
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
S100A4 and metastasis: a small actor playing many roles
Kjetil Boye1, Gunhild M Maelandsmo
1Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, N-0310 Oslo, Norway. kjetil.boye@rr-research.no
The American Journal of Pathology
|December 19, 2009
Summary
The calcium-binding protein S100A4 (S100A4) drives cancer metastasis and impacts patient outcomes. This review details S100A4
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- S100A4 protein is implicated in promoting cancer metastasis across various tumor types.
- Its expression correlates with patient prognosis and survival.
- S100A4 exhibits diverse biological functions, including regulation of angiogenesis, cell survival, motility, and invasion.
Purpose of the Study:
- To review the evidence linking S100A4 to cancer metastasis.
- To elucidate the mechanisms through which S100A4 contributes to tumor progression.
Main Methods:
- Literature review of experimental animal models and human tumor studies.
- Analysis of S100A4 localization (nucleus, cytoplasm, extracellular space).
- Synthesis of data on S100A4's biological functions relevant to metastasis.
Main Results:
- Consistent evidence demonstrates S100A4's role in promoting metastasis in experimental models.
- S100A4 expression levels are a significant prognostic marker in multiple cancers.
- S100A4 influences key cellular processes critical for tumor spread.
Conclusions:
- S100A4 is a key driver of cancer metastasis.
- Understanding S100A4's mechanisms is crucial for developing targeted anti-metastatic therapies.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

